ClinicalTrials.Veeva

Menu

RESISTANCE VERSUS AEROBIC EXERCISES ON Breast Cancer Patients

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Breast Cancer

Treatments

Other: resisted exercises
Device: Treadmill

Study type

Interventional

Funder types

Other

Identifiers

NCT04656457
P.T.REC/012/002968

Details and patient eligibility

About

The purpose of the study is to evaluate which is more effective resistance or aerobic exercises on cancer related fatigue and immunity in breast cancer patients undergoing adjuvant chemotherapy.

Full description

The problem of cancer related fatigue and decreased immunity, as a result of treatment with adjuvant chemotherapy in breast cancer patients is not well known.

Fatigue and decreased immunity have a negative impact on work, social relationships, mood, and daily activities and cause significant impairment in overall quality of life, Furthermore the need of this study is developed from the lack of information in the published studies about the effect of the treatment with chemotherapy among breast cancer patients on inducing fatigue and decreasing immunity and the effect of resistance and aerobic exercises on improving these changes.

Enrollment

60 estimated patients

Sex

Female

Ages

30 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

The subject selection will be according to the following criteria:

  1. Age range from 30-60 years.
  2. Females post mastectomy only will participate in the study.
  3. All patients undergoing adjuvant chemotherapy and have cancer related fatigue and decreased immunity.
  4. All patients enrolled to the study will have their informed consent.

Exclusion criteria

  • The potential participants will be excluded if they meet one of the following criteria:

    1. Age more than 60 years or less than 30 years.
    2. Another concurrent malignant disease.
    3. Subjects suffering from any condition for which resistance or aerobic exercises contraindicated as metastasis, sever osteoporosis and cardiac diseases.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

resistance exercises
Active Comparator group
Description:
Resistance exercises will be involved in this technique are for upper and lower limb (Exercise program including shoulder flexion, abduction and horizontal adduction, elbow extension and flexion, calf raise, leg extension and squatting) three times daily and five times per week. The 1 repetition maximum (1RM) is measured at baseline and following the intervention. Initially, participants will do two circuits using 50% of their 1RM and repeat them 10 times for the first and second weeks, progressing to two circuits, using 60% of their 1RM and repeat 10 times for the third and fourth weeks. In fifth and sixth weeks, participants will do three circuits using 60% of their 1RM and repeat 10 times. In the last 6 weeks, patients will do three circuits using 70% of their 1RM and repeat 10 times. Time of exercise equal time of rest
Treatment:
Other: resisted exercises
aerobic exercise
Active Comparator group
Description:
Aerobic training (AT) program of submaximal intensity will include a 45-minute session five times per week under the supervision of the researcher. Aerobic exercise will consist of three phases: warm-up, training and cool down. At the beginning of exercise session, subjects will have a ten-minute warm-up. The warm up protocol will be slowly running on treadmill. Then, the warm-up phase will be followed by the training phase. At baseline, the training phase will be commenced with two 30- minute running on treadmill at 50% of their maximal heart rate (MHR) in the first week and increased to 70% MHR by the final week of training. By the end of exercise session, subjects will have a five-minute cool down. The cool down protocol will be slowly running on treadmill. The vital measures such as HR and blood pressure was monitored before patient left the department (Dimeo et al.,2016), maximum heart rate will be calculated using the formula: (HR Max =220- age)
Treatment:
Device: Treadmill

Trial contacts and locations

1

Loading...

Central trial contact

Amal mo abdel baky, Professor; Lamiaa sa tolba, ASS.lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems